205
Views
2
CrossRef citations to date
0
Altmetric
Articles

Enhanced hemocompatibility of a PEGilated polycarbonate based segmented polyurethane

, , , ORCID Icon, , , , & show all
Pages 531-539 | Received 18 Jul 2020, Accepted 26 Nov 2020, Published online: 16 Dec 2020
 

Abstract

The risk of clot formation in blood-contacting devices is a significant concern. Therefore, development of biomaterials with improved hemocompatibility is a clinical need. Altering surface properties is an effective strategy to enhance the hemocompatibility. We have investigated the effect of hydrophilic polyethylene glycol (PEG) amount over the hydrophobic polycarbonate (PC) on hemocompatibility of polyurethanes. The presence of PEG on the surface was evaluated using ATR, AFM, and WCA. At above 20% of PEG to PC ratios, exhibit zero WCA, considerable improvement in hemocompatibility, was achieved. The results indicated the synthesized PUs could be used as coatings of cardiovascular devices.

Graphical Abstract

Additional information

Funding

The authors gratefully acknowledge financial support from the Basque Government and the University of the Basque Country for funding this work through projects IT 1313-19 and GIU19/077. Technical and human support provided by Macro-behavior- Mesostructure Nanotechnology SGIker Service of UPV/EHU and Ms. Azar Najafi are also gratefully acknowledged.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.